Catalog analysis: CISA added this entry on August 18, 2026. The entry reflects catalog information retrieved on August 31, 2026, not a snapshot archived on the inclusion date. This site’s publication date is shown separately. Check current vendor guidance before acting.
What the vulnerability is
CVE-2026-59310 is a path traversal vulnerability (CWE-22) affecting Broadcom VMware vCenter. According to CISA, this flaw could allow a threat actor who has network access to the vCenter instance to execute arbitrary code on the system.
Exposure and applicability
This vulnerability is highly relevant to healthcare providers, health plans, and business associates that utilize VMware vCenter to manage their virtualized server environments. Because vCenter often oversees the hypervisors hosting electronic Protected Health Information (ePHI), clinical applications, and patient databases, a compromise at this management layer could impact the confidentiality and availability of critical healthcare operations.
CISA added this vulnerability to its Known Exploited Vulnerabilities catalog on August 18, 2026, indicating that it is being actively exploited in the wild. While CISA has set a remediation deadline of August 21, 2026, for federal agencies, private healthcare entities should evaluate their exposure based on their own risk management frameworks.
Remediation priorities
Our analysis suggests the following prioritized actions for healthcare IT and security teams:
- Apply Vendor Mitigations: The primary priority is to implement the mitigations provided by Broadcom. This addresses the root path traversal flaw to reduce the likelihood of unauthorized code execution.
- Network Segmentation Review: Ensure that vCenter management interfaces are not exposed to the public internet and are restricted to authorized administrative networks. This limits the potential entry paths for a threat actor.
- Forensic Triage: In alignment with CISA’s guidance, organizations should perform forensic triage to determine if the vulnerability has already been exploited within their environment before or during the patching process.
How to validate remediation
To verify that exposure has been reduced, administrators should:
* Confirm the application of vendor-supplied updates or mitigations through version checks and official patch logs.
* Review network access control lists (ACLs) and firewall rules to ensure vCenter is isolated from untrusted network segments.
* Audit system logs for unauthorized access attempts or unusual execution patterns consistent with path traversal activity.
Limits and open questions
It remains unknown whether this vulnerability has been utilized in specific ransomware campaigns targeting the healthcare sector. Additionally, while mitigations can reduce risk, they may not eliminate all residual risks associated with compromised administrative credentials or internal lateral movement. Organizations should continue to coordinate with clinical engineering to ensure that updates to the virtualization layer do not disrupt the availability of critical medical device controllers or patient-care systems.
Source and editorial note
CVE-2026-59310: Broadcom VMware vCenter Path Traversal Vulnerability · Source date: August 18, 2026 · Retrieved August 31, 2026.
Material facts are tied to the cited primary source. Recommendations are independent defensive analysis unless attributed to the source. Confirm consequential decisions against current authoritative guidance.
Request a healthcare security assessment
Turn healthcare security intelligence into action.
Discuss your environment, priorities, and the evidence needed to validate safeguards.
Request a healthcare assessment ↗